JOLT HEALTH INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | -.--% |
|
-.--% | -.--% |
| 04-30 | Jolt Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-27 | Jolt Health Inc. announced that it has received CAD 0.5 million in funding | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 11.02 | 2.521 | 0.3864 |
| Enterprise Value (EV) 1 | 10.73 | 2.625 | 0.3844 |
| P/E ratio | -0.79 x | -0.58 x | -0.43 x |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | -5,109,198 x | -1,701,124 x | - |
| EV / FCF | -13,913,448 x | -3,260,277 x | 2,735,787 x |
| FCF Yield | -0% | -0% | 0% |
| Price to Book | 9.1 x | 13.4 x | -3.05 x |
| Nbr of stocks (in thousands) | 31,492 | 50,423 | 77,290 |
| Reference price 2 | 0.3500 | 0.0500 | 0.005000 |
| Announcement Date | 22-05-02 | 23-05-01 | 24-04-29 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales | - | - | - | - |
| EBITDA | - | -2.1 | -1.543 | - |
| EBIT 1 | -0.1795 | -2.137 | -1.58 | -0.3761 |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) 1 | -0.1729 | -9.521 | -3.579 | -0.7657 |
| Net income 1 | -0.1729 | -9.521 | -3.579 | -0.7657 |
| Net margin | - | - | - | - |
| EPS | - | -0.4438 | -0.0866 | -0.0118 |
| Free Cash Flow | - | -0.7712 | -0.8051 | 0.1405 |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 21-09-23 | 22-05-02 | 23-05-01 | 24-04-29 |
1CAD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | - | - | 0.1 | - |
| Net Cash position 1 | 0.32 | 0.29 | - | 0 |
| Leverage (Debt/EBITDA) | - | - | -0.0672 x | - |
| Free Cash Flow | - | -0.77 | -0.81 | 0.14 |
| ROE (net income / shareholders' equity) | - | -1,162% | -512% | -2,515% |
| ROA (Net income/ Total Assets) | - | -103% | -74.9% | -39.4% |
| Assets 1 | - | 9.245 | 4.781 | 1.944 |
| Book Value Per Share 2 | 0.0100 | 0.0400 | 0 | -0 |
| Cash Flow per Share 2 | 0.0200 | 0.0100 | 0 | 0 |
| Capex | - | - | - | - |
| Capex / Sales | - | - | - | - |
| Announcement Date | 21-09-23 | 22-05-02 | 23-05-01 | 24-04-29 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 464K | |
| +32.36% | 698B | |
| +26.51% | 568B | |
| -4.40% | 358B | |
| +19.46% | 328B | |
| +3.50% | 283B | |
| +16.34% | 238B | |
| +6.68% | 203B | |
| -9.08% | 198B | |
| +8.62% | 165B |
- Stock Market
- Equities
- JOLT Stock
- Financials Jolt Health Inc.